Evidence map›Paper›PMID 35943189›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2022

Zinc pyrithione is a potent inhibitor of PL

Jerneja Kladnik, Ana Dolinar, Jakob Kljun, David Perea, Judith Grau-Expósito, Meritxell Genescà, Marko Novinec, Maria J Buzon, Iztok Turel

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Synthesis of aACS omega · 2025
    Article
  4. Article
  5. Article
  6. Coordination chemistry suggests that independently observed benefits of metformin and ZnBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Metallo-antiviral aspirants:European journal of medicinal chemistry reports · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Zinc pyrithione is a potent inhibitor of PLJournal of enzyme inhibition and medicinal chemistry · 2022
    Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jerneja KladnikFaculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Ana DolinarFaculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Jakob KljunFaculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
David PereaInfectious Diseases Department, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, VHIR Task Force COVID-19, Barcelona, Spain.
Judith Grau-ExpósitoInfectious Diseases Department, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, VHIR Task Force COVID-19, Barcelona, Spain.
Meritxell GenescàInfectious Diseases Department, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, VHIR Task Force COVID-19, Barcelona, Spain.
Marko NovinecFaculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Maria J BuzonInfectious Diseases Department, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, VHIR Task Force COVID-19, Barcelona, Spain.
Iztok TurelFaculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
University of Ljubljana · SIUniversitat Autònoma de Barcelona · ESVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc pyrithione (

Indexed as

COVID-19 Drug TreatmentRutheniumAntiviral AgentsCathepsin LHumansOrganometallic CompoundsPyridinesSARS-CoV-2Antiviral AgentsCathepsin LOrganometallic CompoundsPyridinespyrithione zincRutheniumAntiviral agentsinhibitionpyrithioneSARS-CoV-2zinc

Identifiers

PMID35943189
PMCPMC9367663
OpenAlexW4291286463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.